What Revenue Does a Behavioral Health Business Need to Attract Buyers?

Behavioral health businesses need at least $1.5M-$2M in revenue with $400K-$500K+ in normalized SDE or EBITDA to attract institutional buyers in 2026. To attract top-tier PE-backed platforms like LifeStance Health, Refresh Mental Health, Mindpath Health, Thriveworks, Octave, ARC Health, Discovery Behavioral Health, and Acadia Healthcare, you generally need $5M+ in revenue and $1M+ EBITDA.

  • Minimum: $1.5M-$2M Revenue for Institutional Buyers
  • Platforms: LifeStance, Refresh, Mindpath, Thriveworks
  • Multiples: 3.0x-10.0x (by size)
  • PE Threshold: $5M+ Revenue

Why does clinician mix matter more than revenue?

Behavioral health buyers are buying recurring revenue tied to credentialed, payor-contracted clinicians who will stay post-close. A practice with 15 W-2 clinicians on restrictive covenants is a much safer asset than a practice with five 1099 contractors who can walk any Tuesday. Buyers discount heavily for 1099-heavy models — I've seen 1.5x-2.5x multiple haircuts on practices that looked strong on the top line but had no clinician retention mechanism. The practices that clear the high end of the multiple range have three things: W-2 employment with enforceable non-competes where state law allows, documented clinician productivity metrics, and a demonstrated ability to hire and credential new clinicians within 60-90 days.

What payor mix do buyers want to see?

The ideal mix in 2026 is 60-80% commercial and Medicare Advantage, with the balance in Medicare and self-pay. Medicaid-heavy practices still sell, but they sell to different buyers — typically Medicaid-focused platforms like ARC Health or regional Medicaid consolidators — at lower multiples (3.0x-5.0x EBITDA range). Self-pay and private-pay-only practices can actually price at the top of the range if they have strong demand and pricing power ($250+ per session rates with steady waitlists). The mix buyers are most cautious about is heavy reliance on a single commercial payor or a network that's in renegotiation. A practice with 40% of revenue from one BCBS contract is meaningfully riskier than the same practice with revenue spread across four to five commercial contracts. For related sector trends, see my urgent care valuation analysis — similar payor dynamics play out there. For broader thinking on what makes a behavioral health business worth more, start with the hub page.

A therapist-owner called me last spring frustrated that three PE platforms had passed on her practice despite $3M in revenue. When we dug in, the issue wasn't size — 85% of her revenue came from three contractor clinicians with no non-compete. Buyers weren't buying a business, they were buying a referral list. We spent nine months shifting those clinicians to W-2, adding two more, and tightening the agreements. She listed again and closed at 6.5x EBITDA with four bidders.

Find Out What Your Behavioral Health Business Is Worth

Start with the free online valuation calculator to see exactly where your practice sits relative to buyer thresholds. Then we can have a confidential conversation about what to strengthen before going to market.

Schedule a Confidential Consultation

Frequently Asked Questions

Why does clinician mix matter more than revenue?
Behavioral health buyers are buying recurring revenue tied to credentialed, payor-contracted clinicians who will stay post-close. A practice with 15 W-2 clinicians on restrictive covenants is a much safer asset than a practice with five 1099 contractors who can walk any Tuesday. Buyers discount heavily for 1099-heavy models — I've seen 1.5x-2.5x multiple haircuts on practices that looked strong on the top line but had no clinician retention mechanism. The practices that clear the high end of the multiple range have three things: W-2 employment with enforceable non-competes where state law allows, documented clinician productivity metrics, and a demonstrated ability to hire and credential new clinicians within 60-90 days.
What payor mix do buyers want to see?
The ideal mix in 2026 is 60-80% commercial and Medicare Advantage, with the balance in Medicare and self-pay. Medicaid-heavy practices still sell, but they sell to different buyers — typically Medicaid-focused platforms like ARC Health or regional Medicaid consolidators — at lower multiples (3.0x-5.0x EBITDA range). Self-pay and private-pay-only practices can actually price at the top of the range if they have strong demand and pricing power ($250+ per session rates with steady waitlists). The mix buyers are most cautious about is heavy reliance on a single commercial payor or a network that's in renegotiation. A practice with 40% of revenue from one BCBS contract is meaningfully riskier than the same practice with revenue spread across four to five commercial contracts. For related sector trends, see my <a href="https://www.johnsalony.com/urgent-care">urgent care valuation analysis</a> — similar payor dynamics play out there.